{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"Anti-thymocyte globulin infuse the 1st dose, minimum of 6 hrs subsequent doses minimum of 4 hrs via a 0.22 micron in-line filter\n\nRituximab, total dose is 28 mg/kg divided in 2 doses (14 mg/kg, days -7 \\& +3) Initial infusion, start rate 50 mg/hour\n\nSirolimus 12 mg orally loading dose on day -3, followed by 4 mg orally single morning daily dose (target serum level 3-12 ng/ml by HPLC).\n\nTacrolimus (IV) dose of 0.03 mg/kg (ideal body weight) every 24hr by continuous infusion starting on Day -3, discontinued once the pt. starts eating \\& the drug will then be given orally at a dose of approximately 4 times the IV dose.\n\n.","id":"OG000","title":"Anti-thymocyte Globulin, Rituximab, Sirolimus, Tacrolimus,"}],"populationDescription":"Study terminated due to lack of funding, no analysis was done for this protocol due to the fact that only four patients were accrued, no data was collected.","reportingStatus":"POSTED","timeFrame":"During the first six months post transplant","title":"Time to Engraftment","type":"PRIMARY"}